Work

Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems

Year: 2010

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Vaccine

DOI: 10.1016/j.vaccine.2010.08.035

Authors: Isabel Leroux-Roels, Marguerite Koutsoukos, Frédéric Clement, Sophia Steyaert, Michel Janssens, Patricia Bourguignon, Kristen Cohen, Marcus Altfeld, Pierre Vandepapelière, Louise Pedneault, Lisa McNally, Geert Leroux-Roels, Gerald Voss

Institutions: Ghent University Hospital, Ghent University, GlaxoSmithKline (Belgium), Harvard University, Massachusetts General Hospital

Language: English

Topic: HIV Research and Treatment

Subfield: Virology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: GlaxoSmithKline, Universiteit Gent

OpenAlex ID: W2085802287

FWCI: 2.926

Cites: 58

Cited by: 76

Related to: 10